PMID: 15385827Sep 24, 2004Paper

Excess fatality from desipramine and dosage recommendations

Therapeutic Drug Monitoring
Yona Amitai, Henri Frischer

Abstract

Higher case fatality rates (CFR) were previously reported from desipramine than for 3 other tricyclic antidepressants (TCAs): amitriptyline, nortriptyline, and imipramine. The database of the American Association of Poison Control Centers (AAPCC) Toxic Exposure Surveillance System (TESS) for the 20 years 1983-2002 was used to evaluate the CFR of desipramine and the other TCAs. The CFR of desipramine was 2.25-, 2.31-, and 2.62-fold the CFR for amitriptyline, nortriptyline, and imipramine, respectively (P < 0.001). Mechanisms of desipramine toxicity and its dosage recommendations are discussed. Desipramine and nortriptyline have higher distribution volumes and erythrocyte/plasma ratios than their parent compounds imipramine and amitriptyline. This implies lower therapeutic plasma levels and reduced doses for desipramine and nortriptyline compared with their parent compounds. Such adjustments have been done for nortriptyline, but not for desipramine. The authors suggest that the high CFR of desipramine might be reduced by lowering its dose, therapeutic plasma level, and maximal pill content.

References

Nov 1, 1978·The American Journal of Psychiatry·D N BaileyP I Jatlow
Oct 1, 1992·Clinical Pharmacology and Therapeutics·U Breyer-PfaffP Baumann
Dec 23, 1992·JAMA : the Journal of the American Medical Association·S KapurJ J Mann
Sep 1, 1992·The American Journal of Emergency Medicine·T L LitovitzB F Schmitz
Sep 1, 1991·The American Journal of Emergency Medicine·T L LitovitzW Klein-Schwartz
Jan 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·M A RiddleD J Cohen
Jun 1, 1990·Annals of Emergency Medicine·F W LavoieR E Weiss
Sep 1, 1990·Therapeutic Drug Monitoring·S H SindrupL F Gram
Sep 1, 1989·The American Journal of Emergency Medicine·T L LitovitzK C Holm
Nov 1, 1989·Journal of the American Academy of Child and Adolescent Psychiatry·J BiedermanA Goldblatt
Sep 1, 1988·The American Journal of Emergency Medicine·T L LitovitzT G Martin
Jun 1, 1987·Clinical Pharmacology and Therapeutics·J C Nelson, P I Jatlow
Sep 1, 1987·The American Journal of Emergency Medicine·T L LitovitzB Schmitz
Oct 24, 1987·British Medical Journal·S Cassidy, J Henry
Sep 1, 1986·The American Journal of Emergency Medicine·T L LitovitzJ C Veltri
Sep 1, 1985·The American Journal of Emergency Medicine·T Litovitz, J C Veltri
Sep 1, 1984·The American Journal of Emergency Medicine·J C Veltri, T L Litovitz
Sep 1, 1995·The American Journal of Emergency Medicine·T L LitovitzR Geller
Jan 28, 1995·BMJ : British Medical Journal·J A HenryE K Sener
Dec 14, 1994·JAMA : the Journal of the American Medical Association·Y Amitai, H Frischer
Sep 1, 1994·The American Journal of Emergency Medicine·T L LitovitzR A Soloway
Sep 1, 1993·The American Journal of Emergency Medicine·T L LitovitzG M Oderda
Jul 1, 1993·Journal of the American Academy of Child and Adolescent Psychiatry·M A RiddleN Ryan
Jul 1, 1993·Journal of the American Academy of Child and Adolescent Psychiatry·T E WilensJ G Flood
Jan 1, 1993·European Journal of Clinical Pharmacology·M L DahlF Sjöqvist
Sep 1, 1996·The American Journal of Emergency Medicine·T L LitovitzW Klein-Schwartz
Jan 1, 1997·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R T CouttsG B Baker
Sep 1, 1997·The American Journal of Emergency Medicine·T L LitovitzJ L Morgan
May 20, 1998·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·N A Buckley, P R McManus
Sep 3, 1998·The American Journal of Emergency Medicine·T L LitovitzM Powers
Sep 25, 1999·The American Journal of Emergency Medicine·T L LitovitzS Lee
Apr 6, 2000·The American Journal of Emergency Medicine·J C Rose, A S Unis
Sep 22, 2000·The American Journal of Emergency Medicine·T L LitovitzB E Benson
Sep 14, 2001·The American Journal of Emergency Medicine·T L LitovitzB E Benson
Oct 5, 2001·Journal of Clinical Pharmacology·K VenkatakrishnanD J Greenblatt
Dec 12, 2001·Clinical Pharmacokinetics·E E KvistL Ståhle
Feb 20, 2002·British Journal of Clinical Pharmacology·Leif BertilssonAyman Al-Shurbaji
Sep 7, 2002·The American Journal of Emergency Medicine·Toby L LitovitzBlaine E Benson
Oct 3, 2003·The American Journal of Emergency Medicine·William A WatsonMary E May

❮ Previous
Next ❯

Citations

Apr 25, 2007·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Alan D WoolfUNKNOWN American Association of Poison Control Centers
May 2, 2007·British Journal of Pharmacology·P K Gillman
Dec 6, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Yona Amitai, Henri Frischer
Sep 18, 2014·Frontiers in Physiology·Nadine BeckmannBärbel Edelmann
Jan 16, 2007·Canadian Journal of Physiology and Pharmacology·Doreen RichardtGert Richardt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
Yona Amitai, Henri Frischer
BMJ : British Medical Journal
J A HenryE K Sener
Psychiatric Services : a Journal of the American Psychiatric Association
Thomas DelateBrenda R Motheral
Journal of the American Academy of Child and Adolescent Psychiatry
Mark A RiddleN Ryan
© 2021 Meta ULC. All rights reserved